Lung Cancer Drug May Treat Breast Cancer
Posted on: Tuesday, 2 May 2006, 03:04 CDT
British scientists say that carboplatin, a drug now used to treat lung and ovarian cancer, may be effective against one type of breast cancer.
Working with mice, a team led by Dr. Andrew Tutt, a consulting oncologist at Guys' and St. Thomas's National Health Service Foundation in London, found that tumors caused by mutations in the BRCA gene were sensitive to carboplatin, which appeared to be up to 20 times more effective than standard therapies.
There is an increasing realization that breast cancer is not just one disease, but that different types of tumors will respond differently to particular drugs, Tutt told the Times of London. This genetically tailored chemotherapy treatment acts in a much more focused manner than standard chemotherapy.
Tutt and his colleagues are recruiting cancer patients with BRCA1 and BRCA2 tumors to compare carboplatin against docetaxel in a clinical trial.
Source: United Press International
Related Articles
- URI Research Couple's Method Targets Cancerous Tumors
- Small Peptide Found To Stop Lung Cancer Tumor Growth In Mice
- High Levels of PEA-15 Reduce Breast Cancer Tumors
- Anavex 7-1037 Reduces Rate of Cancer Tumor Growth 69% in Pre-Clinical Studies, Compared to Currently Marketed Drug Dacarbazine Showing No Measurable Activity
- Race, Ethnic Differences in Cancer Tumors
- Synthetic Kills Some Cancer Tumors
- Wine, Produce, Tea Prevent Cancer Tumors
- Laura Bush Had Skin Cancer Tumor Removed
- Subtypes of Lung Cancer Tumors Identified
- Endocare Receives FDA 510K Clearance to Market New Nitrogen-Based Cryoablation System for Destroying Tissue and Cancerous Tumors
 |
 |
User Comments (0)
RSS Feeds